Warner Financial’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$475K Hold
19,719
0.14% 95
2026
Q1
$554K Hold
19,719
0.19% 78
2025
Q4
$491K Hold
19,719
0.17% 84
2025
Q3
$502K Hold
19,719
0.19% 76
2025
Q2
$478K Hold
19,719
0.2% 70
2025
Q1
$500K Sell
19,719
-791
-4% -$20.7K 0.22% 71
2024
Q4
$544K Sell
20,510
-18,083
-47% -$490K 0.23% 71
2024
Q3
$1.12M Hold
38,593
0.5% 43
2024
Q2
$1.08M Hold
38,593
0.53% 42
2024
Q1
$1.07M Sell
38,593
-792
-2% -$22K 0.54% 45
2023
Q4
$1.13M Buy
39,385
+1,583
+4% +$47.9K 0.64% 37
2023
Q3
$1.25M Sell
37,802
-556
-1% -$19.7K 0.83% 29
2023
Q2
$1.41M Hold
38,358
0.91% 27
2023
Q1
$1.56M Buy
38,358
+9,969
+35% +$431K 1.08% 23
2022
Q4
$1.46M Hold
28,389
1.11% 21
2022
Q3
$1.24M Hold
28,389
1% 24
2022
Q2
$1.49M Buy
+28,389
New +$1.45M 1.37% 16

Other funds holding PFE

Warner Financial's PFE Position: Q2 2026 in Review

Warner Financial held its Pfizer (PFE) position steady in Q2 2026 at 19,719 shares worth $475K. The position accounts for 0.14% of the portfolio, ranked #95.

Warner Financial first reported a position in PFE in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.56M in Q1 2023. 1,342 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Warner Financial held 19,719 shares of Pfizer worth $475K as of Q2 2026.
  • Warner Financial left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up 0.14% of Warner Financial's portfolio in Q2 2026, its #95 holding.
  • Warner Financial first reported a position in Pfizer in Q2 2022 and has held it in 17 quarters since.
  • Warner Financial's Pfizer position peaked at $1.56M in Q1 2023.
  • 1,342 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Warner Financial's 13F filing for Q2 2026, filed 9 Jul 2026.